https://www.selleckchem.com/mTOR.html
The study aimed to explore the protective potential of rosuvastatin (ROSS), an oral antihyperlipidemic drug against doxorubicin (DOXO) induced cardio toxicity in rats. Cardiac toxicity was induced by DOXO injection (10 mg/kg, ), once on the 20 day of the experiment. Except for the control rats, all were received DOXO and the study was continued for up to 21 days. The influence of ROSS on acute treatment was analyzed by quantification of cardiac marker enzymes such as creatine kinase-MB (CK-M, lactate dehydrogenase (LDH) and liver marker enzymes l
Like
Comment
Share
